Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B

Cellular Immunology

Volumn 279, Issue 1, 2012, Pages 109-115

  Ratnam, Dilip T ^a,b   Sievert, William ^a,b   Visvanathan, Kumar ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Hepatitis B; Interferon ; Natural killer cells; Toll like receptors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CD69 ANTIGEN; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST;

ADULT; ARTICLE; CELL FUNCTION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; RECOMBINANT PROTEINS; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 84871649406     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.09.005     Document Type: Article

References (36)

1. Lanier L.L. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 2008, 8:259-268.
2. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
3. Dokun A.O., Chu D.T., Yang L., Bendelac A.S., Yokoyama W.M. Analysis of in situ NK cell responses during viral infection. J. Immunol. 2001, 167:5286-5293.
4. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999, 17:189-220.
5. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 2001, 19:65-91.
6. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284:825-829.
7. Guy C.S., Mulrooney-Cousins P.M., Churchill N.D., Michalak T.I. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with Woodchuck hepadnavirus. J. Virol. 2008, 82:8579-8591.
8. Fisicaro P., Valdatta C., Boni C., Massari M., Mori C., Zerbini A., Orlandini A., Sacchelli L., Missale G., Ferrari C. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 2009, 58:974-982.
9. Dunn C., Peppa D., Khanna P., Nebbia G., Jones M., Brendish N., Lascar R.M., Brown D., Gilson R.J., Tedder R.J., Dusheiko G.M., Jacobs M., Klenerman P., Maini M.K. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009, 137:1289-1300.
10. Kimura K., Kakimi K., Wieland S., Guidotti L.G., Chisari F.V. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J. Immunol. 2002, 169:5188-5195.
11. Kimura K., Kakimi K., Wieland S., Guidotti L.G., Chisari F.V. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J. Virol. 2002, 76:10702-10707.
12. Oliviero B., Varchetta S., Paudice E., Michelone G., Zaramella M., Mavilio D., De Filippi F., Bruno S., Mondelli M.U. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009, 137:1151-1160. 1160 e1-7.
13. Peppa D., Micco L., Javaid A., Kennedy P.T., Schurich A., Dunn C., Pallant C., Ellis G., Khanna P., Dusheiko G., Gilson R.J., Maini M.K. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 2010, 6:e1001227.
14. Tjwa E.T., van Oord G.W., Hegmans J.P., Janssen H.L., Woltman A.M. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J. Hepatol. 2010, 54:209-218.
15. Chen Y., Sun R., Jiang W., Wei H., Tian Z. Liver-specific HBsAg transgenic mice are over-sensitive to poly(I:C)-induced liver injury in NK cell-and IFN-γ-dependent manner. J. Hepatol. 2007, 47:183-190.
16. Chen Y., Wei H., Sun R., Dong Z., Zhang J., Tian Z. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 2007, 46:706-715.
17. Dunn C., Brunetto M., Reynolds G., Christophides T., Kennedy P.T., Lampertico P., Das A., Lopes A.R., Borrow P., Williams K., Humphreys E., Afford S., Adams D.H., Bertoletti A., Maini M.K. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 2007, 204:667-680.
18. Lauzon N.M., Mian F., MacKenzie R., Ashkar A.A. The direct effects of toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell. Immunol. 2006, 241:102-112.
19. Isogawa M., Robek M.D., Furuichi Y., Chisari F.V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J. Virol. 2005, 79:7269-7272.
20. Wu J., Lu M., Meng Z., Trippler M., Broering R., Szczeponek A., Krux F., Dittmer U., Roggendorf M., Gerken G., Schlaak J.F. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 2007, 46:1769-1778.
21. Visvanathan K., Skinner N., Thompson A., Riordan S., Sozzi V., Edwards R., Rodgers S., Kurtovic J., Chang J., Lewin S., Desmond P., Locarnini S. Regulation of toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007, 45:102-110.
22. Wu J., Meng Z., Jiang M., Pei R., Trippler M., Broering R., Bucchi A., Sowa J.P., Dittmer U., Yang D., Roggendorf M., Gerken G., Lu M., Schlaak J.F. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 2009, 49:1132-1140.
23. Cheng J., Imanishi H., Morisaki H., Liu W., Nakamura H., Morisaki T., Hada T. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NF[kappa]B pathway in a human monocytic cell line, THP-1. J. Hepatol. 2005, 43:465-471.
24. Wei C., Ni C., Song T., Liu Y., Yang X., Zheng Z., Jia Y., Yuan Y., Guan K., Xu Y., Cheng X., Zhang Y., Yang X., Wang Y., Wen C., Wu Q., Shi W., Zhong H. The hepatitis b virus x protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J. Immunol. 2010, 185:1158-1168.
25. Duan X., Wang M., Li H., Zhuang H., Xu D., Wang F. Decreased frequency and function of circulating plasmocytoid dendritic cells (pdc) in hepatitis B virus infected humans. J. Clin. Immunol. 2004, 24:637-646.
26. Ratnam D.T., Visvanathan K., Sievert W. Plasmacytoid dendritic cell function is impaired in chronic hepatitis B infection. Hepatology 2008, 48:688A.
27. van der Molen R., Sprengers D., Binda R., de Jong E., Niesters H., Kusters J.J., Kwekkeboom J., Janssen H. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004, 40:738-746.
28. Xie Q., Shen H.-C., Jia N.-N., Wang H., Lin L.-Y., An B.-Y., Gui H.-L., Guo S.-M., Cai W., Yu H., Guo Q., Bao S. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect. 2009, 11:515-523.
29. Xu N., Yao H.P., Lv G.C., Chen Z. Downregulation of TLR7/9 leads to deficient production of IFN-alpha from plasmacytoid dendritic cells in chronic hepatitis B. Inflamm. Res. 2012.
30. Woltman A.M., Op den Brouw M.L., Biesta P.J., Shi C.C., Janssen H.L. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 2011, 6:e15324.
31. Shi C.C., Tjwa E.T., Biesta P.J., Boonstra A., Xie Q., Janssen H.L., Woltman A.M. Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells. J. Viral Hepatol. 2012, 19:e26-e33.
32. 3 secretion and cytotoxic activity by plasmacytoid dendritic cells is regulated through overlapping but different pathways. Sensors 2009, 9:386-403.
33. Tjwa E.T., van Oord G.W., Hegmans J.P., Janssen H.L., Woltman A.M. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J. Hepatol. 2011, 54:209-218.
34. Poli A., Michel T., Theresine M., Andres E., Hentges F., Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009, 126:458-465.
35. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56 (bright) subset. Blood 2001, 97:3146-3151.
36. Ishiyama K., Ohdan H., Ohira M., Mitsuta H., Arihiro K., Asahara T. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 2006, 43:362-372.